CIK: 0001388551
申告総資産額
$402.4万
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GLD | Spdr Gold Shares | ETF-コモディティ | 64.50% | +17.00% | -4.42% | |
| 2 | BRK-B | Berkshire Hathaway Inc-cl B | 株式-その他 | 8.34% | +0.32% | +9.06% | |
| 3 | SYRE | Spyre Therapeutics INC | 株式-その他 | 6.83% | -6.83% | EXIT | |
| 4 | BRD1EUR | Mind Medicine Mindmed INC | 株式-その他 | 4.91% | -4.91% | EXIT | |
| 5 | KYTX | Kyverna Therapeutics INC | 株式-その他 | 4.12% | -0.09% | -18.31% | |
| 6 | CMPX | Compass Therapeutics INC | 株式-その他 | 3.70% | -3.70% | EXIT | |
| 7 | LXEO | Lexeo Therapeutics INC | 株式-その他 | 3.24% | -1.25% | -19.55% | |
| 8 | XFOR | X4 Pharmaceuticals INC | 株式-その他 | 1.45% | +0.15% | — | |
| 9 | IKT | Inhibikase Therapeutics INC | 株式-その他 | 1.36% | -0.17% | +73.57% | |
| 10 | SABS | Sab Biotherapeutics INC | 株式-その他 | 0.92% | -0.92% | EXIT | |
| 11 | CNTX | Context Therapeutics INC | 株式-その他 | 0.63% | -0.63% | EXIT |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | GLD | Spdr Gold Shares | +53.2% | -4.42% | 減少 |
| 2 | BRK-B | Berkshire Hathaway Inc-cl B | +6.9% | +9.06% | 増加 |
| 3 | BRD1EUR | Mind Medicine Mindmed INC | +3.5% | -41.92% | 減少 |
| 4 | KYTX | Kyverna Therapeutics INC | +3.5% | -18.31% | 減少 |
| 5 | CMPX | Compass Therapeutics INC | +2.9% | -44.87% | 減少 |
| 6 | LXEO | Lexeo Therapeutics INC | +2.7% | -19.55% | 減少 |
| 7 | IKT | Inhibikase Therapeutics INC | +1.2% | +73.57% | 増加 |
| 8 | SABS | Sab Biotherapeutics INC | +0.8% | -3.73% | 減少 |
| 9 | CNTX | Context Therapeutics INC | +0.6% | — | 変化なし |
| 10 | RZLT | Rezolute INC | — | EXIT | 全売却 |
| 11 | SYRE | Spyre Therapeutics INC | — | NEW | 新規購入 |
| 12 | ELVN | Enliven Therapeutics INC | — | EXIT | 全売却 |
| 13 | BCAX | Bicara Therapeutics INC | — | EXIT | 全売却 |
| 14 | XFOR | X4 Pharmaceuticals INC | — | NEW | 新規購入 |